alabdy
07-19-2022, 04:08 AM
The Food and Drug Administration authorized Pfizer’s Covid-19 vaccine for emergency use on Friday, clearing the way for millions of highly vulnerable people to begin receiving the vaccine within days.
The authorization is a historic turning point in a pandemic that has taken more than 290,000 lives in the United States. With the decision, the United States becomes the sixth country — in addition to Britain, Bahrain, Canada, Saudi Arabia and Mexico — to clear the vaccine. Today, we ask the science and health reporter Donald G. McNeil Jr. what might happen next.
Guest: Donald G. McNeil Jr. (https://www.nytimes.com/by/donald-g-mcneil-jr?smid=pc-thedaily), a science and health reporter for The New York Times.
For an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter (https://www.nytimes.com/newsletters/the-daily?module=inline). You can read the latest edition here (https://www.nytimes.com/column/the-daily-newsletter).
Background reading:
Pfizer has a deal with the U.S. government to supply 100 million doses of the vaccine (https://www.nytimes.com/2020/12/11/health/pfizer-vaccine-authorized.html?type=styln-key-updates&index=0&module=hub_keyUpdates®ion=hub&action=click&pgtype=legacyCollection) by next March. Under that agreement, the shots will be free to the public.
The vaccines are on their way, but experts still say a difficult winter of coronavirus infection and death (https://www.nytimes.com/2020/11/30/health/coronavirus-vaccines-treatments.html) lies ahead.
For more information on today’s episode, visit nytimes.com/thedaily (http://nytimes.com/thedaily?smid=pc-thedaily)
أكثر... (https://www.nytimes.com/the-daily)
The authorization is a historic turning point in a pandemic that has taken more than 290,000 lives in the United States. With the decision, the United States becomes the sixth country — in addition to Britain, Bahrain, Canada, Saudi Arabia and Mexico — to clear the vaccine. Today, we ask the science and health reporter Donald G. McNeil Jr. what might happen next.
Guest: Donald G. McNeil Jr. (https://www.nytimes.com/by/donald-g-mcneil-jr?smid=pc-thedaily), a science and health reporter for The New York Times.
For an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter (https://www.nytimes.com/newsletters/the-daily?module=inline). You can read the latest edition here (https://www.nytimes.com/column/the-daily-newsletter).
Background reading:
Pfizer has a deal with the U.S. government to supply 100 million doses of the vaccine (https://www.nytimes.com/2020/12/11/health/pfizer-vaccine-authorized.html?type=styln-key-updates&index=0&module=hub_keyUpdates®ion=hub&action=click&pgtype=legacyCollection) by next March. Under that agreement, the shots will be free to the public.
The vaccines are on their way, but experts still say a difficult winter of coronavirus infection and death (https://www.nytimes.com/2020/11/30/health/coronavirus-vaccines-treatments.html) lies ahead.
For more information on today’s episode, visit nytimes.com/thedaily (http://nytimes.com/thedaily?smid=pc-thedaily)
أكثر... (https://www.nytimes.com/the-daily)